PAP therapy

DEVICE4 trials

Sponsors

Vice chancellor for research, Tehran University of Medical Sciences, University of Tennessee, University of Michigan, University of Miami

Conditions

Fat DisorderMultiple SclerosisObstructive Sleep ApneaObstructive Sleep Apnea. A disorder characterized by cessation of breathing for short periods during sleep

Phase 1

Effects of Positive Airway Pressure (PAP) in Children With Obstructive Sleep Apnea (OSA)

University of TennesseeObstructive Sleep Apnea

Start: 2010-07-31End: 2016-11-30Updated: 2016-11-04

Unknown Phase

CPAP to Treat Cognitive Dysfunction in MS

CompletedNCT02544373

University of MichiganMultiple Sclerosis

Start: 2015-11-12End: 2021-06-25Updated: 2022-09-14

The effect of positive airway pressure (PAP) therapy on the components of metabolic syndrome in obstructive sleep apnea (OSA)

RecruitingIRCT2017012832249N1

Vice chancellor for research, Tehran University of Medical SciencesObstructive Sleep Apnea. A disorder characterized by cessation of breathing for short periods during sleep

Start: 2017-04-21Target: 40Updated: 2018-02-22

Metabolism and Sleep Apnea Treatment

RecruitingNCT05539716

University of MiamiFat Disorder, Obstructive Sleep Apnea

Start: 2022-05-20End: 2027-09-01Target: 100Updated: 2026-03-23

Related Papers

Sleep-disordered breathing and neurocognitive function in multiple sclerosis: Differential associations across cognitive domains

Multiple Sclerosis Journal2023-05-1711 citations